Article
Acute generalized exanthematous pustulosis following treatment with remdesivir in a patient with SARS-CoV-2 infection, a case report
2022-02-22
Abstract excerpt
We hereby, present the first case of Acute generalized exanthematous pustulosis (AGEP) following treatment with remdesivir in a patient with COVID-19 without hydroxychloroquine use which serves as a reminder for considering remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e31bf47e-bcff-53e3-861f-520840b6fcf7
- DOI
- 10.22541/au.164555940.08198265/v1
